Arda presents at 8th Annual Antifibrotics Drug Development Conference

Arda’s CEO, Adam Freund, and CSO, Scott Turner, will be participating in the 8th Annual Antifibrotics drug development conference in Boston from November 19-21, 2024. Dr. Freund will be presenting exciting new data about our lead programs depleting pathogenic mesenchymal populations in multiple types of fibrosis, while Dr. Turner will be participating in a panel discussion about collaborative strategies for advancing antifibrotic drug development across diverse disease indications.